We are live on
!
Find out more
Two Sigma Advisers Portfolio holdings
AUM
$51.4B
1-Year Est. Return
31.07%
This Fund
S&P 500
This Quarter
Est. Return
+2.14%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$36.9B
AUM Growth
-$216M
(-0.58%)
Cap. Flow
-$321M
Cap. Flow
% of AUM
-0.87%
Top 10 Holdings %
Top 10 Hldgs %
8.45%
Holding
2,522
New
303
Increased
944
Reduced
1,005
Closed
237
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$291M |
| 2 |
PepsiCo
PEP
|
+$240M |
| 3 |
Chevron
CVX
|
+$231M |
| 4 |
Amazon
AMZN
|
+$183M |
| 5 |
Citigroup
C
|
+$175M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$277M |
| 2 |
Lowe's Companies
LOW
|
+$253M |
| 3 |
Home Depot
HD
|
+$246M |
| 4 |
Danaher
DHR
|
+$174M |
| 5 |
Cisco
CSCO
|
+$161M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 17.03% |
| 2 | Technology | 15.23% |
| 3 | Healthcare | 11.73% |
| 4 | Industrials | 11.36% |
| 5 | Consumer Staples | 8.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1601
Travere Therapeutics
TVTX
$5.27B
| $879K | ﹤0.01% |
39,300
+2,600
| +7% | +$61.9K |
|
1602
Lands' End
LE
$375M
| $878K | ﹤0.01% |
37,600
+2,700
| +8% | +$49.9K |
|
|
CHFN
1603
DELISTED
Charter Financial Corp
CHFN
| $878K | ﹤0.01% |
43,079
-700
| -2% | -$13.6K |
|
|
STB
1604
DELISTED
Student Transportation Inc
STB
| $878K | ﹤0.01% |
117,264
-131,704
| -53% | -$868K |
|
1605
Chemed
CHE
$6.76B
| $877K | ﹤0.01% |
3,214
-5,061
| -61% | -$1.34M |
|
1606
Metropolitan Bank Holding Corp
MCB
$1.13B
| $876K | ﹤0.01% |
20,800
+4,800
| +30% | +$214K |
|
|
TCS
1607
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
| $874K | ﹤0.01% |
10,707
+320
| +3% | +$24.1K |
|
1608
Great Southern Bancorp
GSBC
$863M
| $868K | ﹤0.01% |
17,380
+2,800
| +19% | +$142K |
|
1609
HealthEquity
HQY
$8.28B
| $866K | ﹤0.01% |
+14,300
| New | +$774K |
|
|
OLP
1610
One Liberty Properties
OLP
$551M
| $866K | ﹤0.01% |
39,170
+4,300
| +12% | +$103K |
|
1611
Bio-Techne
TECH
$11.2B
| $866K | ﹤0.01% |
+22,944
| New | +$811K |
|
|
NPKI
1612
NPK International
NPKI
$1.19B
| $866K | ﹤0.01% |
106,891
-18,900
| -15% | -$166K |
|
|
MINI
1613
DELISTED
Mobile Mini Inc
MINI
| $863K | ﹤0.01% |
19,828
+4,400
| +29% | +$179K |
|
1614
REX American Resources
REX
$1.44B
| $859K | ﹤0.01% |
70,800
-600
| -0.8% | -$8.19K |
|
1615
Stellus Capital Investment Corp
SCM
$204M
| $859K | ﹤0.01% |
74,645
-26,700
| -26% | -$322K |
|
1616
Matsons
MATX
$6.22B
| $858K | ﹤0.01% |
29,970
+3,000
| +11% | +$93.8K |
|
1617
Acacia Research
ACTG
$447M
| $852K | ﹤0.01% |
243,538
+5,400
| +2% | +$19.8K |
|
1618
Freshpet
FRPT
$2.92B
| $852K | ﹤0.01% |
51,800
+4,700
| +10% | +$86.9K |
|
1619
AXT Inc
AXTI
$3.13B
| $851K | ﹤0.01% |
117,400
+37,700
| +47% | +$306K |
|
|
VSTO
1620
DELISTED
Vista Outdoor Inc.
VSTO
| $851K | ﹤0.01% |
52,128
+32,200
| +162% | +$523K |
|
|
MDSO
1621
DELISTED
Medidata Solutions, Inc.
MDSO
| $848K | ﹤0.01% |
+13,498
| New | +$898K |
|
1622
Ribbon Communications
RBBN
$359M
| $845K | ﹤0.01% |
165,613
-70,062
| -30% | -$453K |
|
1623
Extreme Networks
EXTR
$3.92B
| $844K | ﹤0.01% |
76,281
-1,195,614
| -94% | -$15.1M |
|
1624
Lloyds Banking Group
LYG
$89B
| $844K | ﹤0.01% |
226,781
+68,459
| +43% | +$265K |
|
|
AIMT
1625
DELISTED
Aimmune Therapeutics
AIMT
| $840K | ﹤0.01% |
+26,400
| New | +$929K |
|
Similar funds
CWM
VRS
FAF
BGIM
CIM
PPFA
Two Sigma Advisers's Q1 2018 Portfolio in Review
As of Q1 2018, Two Sigma Advisers held 2,522 positions worth $36.9B, down 0.58% from $37.1B the previous quarter. Its ten largest holdings account for 8.4% of the portfolio.
Two Sigma Advisers's Q1 2018 filing shows 303 new, 944 increased, 1,005 reduced and 237 closed positions. Its largest new stake was Procter & Gamble: 3,490,366 shares worth $277M. The largest sale was Amgen, an estimated $277M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 17% of assets, up from 14% a quarter earlier, followed by Technology and Healthcare.
- Two Sigma Advisers's largest Q1 2018 buy was Procter & Gamble: 3,490,366 shares worth $277M.
- Two Sigma Advisers added most to PepsiCo in Q1 2018, an estimated $240M increase.
- Two Sigma Advisers's biggest Q1 2018 reduction was Amgen, cutting an estimated $277M.
- Two Sigma Advisers fully exited Constellation Brands in Q1 2018, selling an estimated $115M.
- Two Sigma Advisers's ten largest holdings make up 8.4% of its $36.9B portfolio in Q1 2018.
- Two Sigma Advisers opened 303 new positions and closed 237 in Q1 2018.
- Two Sigma Advisers's portfolio value fell 0.58% quarter-over-quarter to $36.9B.
Based on Two Sigma Advisers's 13F filing for Q1 2018, filed 15 May 2018.